Get the Stockscreener App
6.19
0.16%
-0.010
After Hours:
6.12
-0.07
-1.13%
Ardelyx Inc stock is traded at $6.19, with a volume of 2.48M.
It is down -0.16% in the last 24 hours and up +44.29% over the past month.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
See More
Previous Close:
$6.20
Open:
$6.15
24h Volume:
2.48M
Relative Volume:
0.57
Market Cap:
$1.49B
Revenue:
$386.15M
Net Income/Loss:
$-56.39M
P/E Ratio:
-26.91
EPS:
-0.23
Net Cash Flow:
$-55.19M
1W Performance:
+3.34%
1M Performance:
+44.29%
6M Performance:
+18.58%
1Y Performance:
-0.48%
1-Day Range:
$6.11
$6.26
1-Week Range:
$5.875
$6.29
52-Week Range:
$3.21
$7.18
Ardelyx Inc Stock (ARDX) Company Profile
Name
Ardelyx Inc
Sector
Industry
Phone
510-745-7047
Address
34175 ARDENWOOD BLVD., FREMONT, CA
Compare ARDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARDX
Ardelyx Inc
|
6.19 | 1.49B | 386.15M | -56.39M | -55.19M | -0.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Ardelyx Inc Stock (ARDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-18-25 | Resumed | H.C. Wainwright | Buy |
| May-02-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-07-25 | Resumed | Ladenburg Thalmann | Buy |
| Mar-04-25 | Initiated | BTIG Research | Buy |
| Nov-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-02-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-05-24 | Initiated | Leerink Partners | Outperform |
| Dec-18-23 | Initiated | Raymond James | Strong Buy |
| Sep-07-23 | Initiated | H.C. Wainwright | Buy |
| Aug-25-23 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-03-23 | Upgrade | Wedbush | Neutral → Outperform |
| Nov-17-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| May-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Dec-01-21 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Oct-14-21 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-21-21 | Downgrade | Jefferies | Buy → Hold |
| Jul-20-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-21 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-23-21 | Initiated | Wedbush | Outperform |
| Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-20-20 | Resumed | Citigroup | Buy |
| Feb-18-20 | Resumed | Jefferies | Buy |
| Feb-12-20 | Initiated | Citigroup | Buy |
| Feb-10-20 | Initiated | Cowen | Outperform |
| Apr-08-19 | Initiated | Piper Jaffray | Overweight |
| Aug-24-18 | Initiated | Jefferies | Buy |
| Mar-19-18 | Resumed | Leerink Partners | Outperform |
| Nov-29-17 | Reiterated | Citigroup | Buy |
| Nov-22-17 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-17-17 | Resumed | Leerink Partners | Outperform |
| Mar-31-16 | Initiated | Ladenburg Thalmann | Buy |
| Mar-09-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-03-16 | Initiated | Citigroup | Buy |
View All
Ardelyx Inc Stock (ARDX) Latest News
What does recent volatility data suggest for Ardelyx Inc.Gold Moves & Risk Managed Investment Signals - Newser
Ardelyx Inc. stock trend outlook and recovery pathLong Setup & Consistent Income Trade Ideas - Newser
How to forecast Ardelyx Inc. trends using time seriesJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - Newser
Is Ardelyx Inc. showing signs of accumulationJuly 2025 Catalysts & Capital Efficiency Focused Strategies - Newser
Volume spikes in Ardelyx Inc. stock – what they meanWeekly Trading Summary & Community Driven Trade Alerts - Newser
Automated trading signals detected on Ardelyx Inc.2025 Macro Impact & Free Fast Entry Momentum Trade Alerts - Newser
Live market analysis of Ardelyx Inc.July 2025 PreEarnings & Growth-Oriented Investment Plans - Newser
Earnings visualization tools for Ardelyx Inc.Trade Signal Summary & High Accuracy Trade Alerts - Newser
Applying chart zones and confluence areas to Ardelyx Inc.Portfolio Performance Report & Stock Market Timing Techniques - Newser
Ardelyx falls 14% as Q1 results miss on both lines - MSN
Institutions Hold 70% of Ardelyx's Shares, Recent Share Price Gain May Indicate Turning Tides - AInvest
After losing 4.0% in the past year, Ardelyx, Inc. (NASDAQ:ARDX) institutional owners must be relieved by the recent gain - Yahoo Finance
Tools to assess Ardelyx Inc.’s risk profileMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - Newser
Ardelyx Executives Sell Shares to Cover Taxes - TradingView
Will Ardelyx Inc. Benefit From Broader Market BounceRate Hike & Weekly High Potential Stock Alerts - kangso.co.kr
Ardelyx's Strategic Momentum in Global Expansion and Pipeline Diversification: A Catalyst for Investor Confidence - AInvest
Ardelyx to Participate in Upcoming Investor Conferences - GlobeNewswire
Biotech Ardelyx Lines Up Four Major Wall Street Healthcare Conference Appearances in September 2025 - Stock Titan
Using Bollinger Bands to evaluate Ardelyx Inc.July 2025 Technicals & Long-Term Safe Investment Ideas - Newser
What makes Ardelyx Inc. stock price move sharplyDay Trade & Weekly Market Pulse Updates - Newser
10 Best Biotech Stocks to Buy Under $10 - Insider Monkey
Will Ardelyx Inc. benefit from macro trendsWeekly Risk Summary & Daily Oversold Stock Bounce Ideas - Newser
Analyzing net buyer seller activity in Ardelyx Inc.July 2025 PostEarnings & Long Hold Capital Preservation Tips - Newser
Does Ardelyx Inc. have consistent dividend growth2025 Key Lessons & Stepwise Entry/Exit Trade Alerts - theviewers.co.kr
What candlestick patterns are forming on Ardelyx Inc.July 2025 Update & Safe Entry Point Alerts - Newser
How Ardelyx Inc. stock performs during market volatility2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
Multi asset correlation models including Ardelyx Inc.Earnings Miss & Daily Volume Surge Trade Alerts - Newser
Ardelyx, Inc. (NASDAQ:ARDX) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Why Ardelyx (ARDX) Is Up 10.6% After Raising IBSRELA Sales Outlook and Reporting Strong Q2 Revenue - simplywall.st
Can you recover from losses in Ardelyx Inc.Rate Cut & Reliable Intraday Trade Alerts - Newser
Statistical indicators supporting Ardelyx Inc.’s strengthEarnings Trend Report & Trade Opportunity Analysis Reports - Newser
Why Ardelyx Inc. is moving todayPortfolio Growth Summary & Advanced Swing Trade Entry Alerts - Newser
Will Ardelyx Inc. outperform the marketMarket Activity Report & AI Forecast for Swing Trade Picks - Newser
Visual trend scoring systems applied to Ardelyx Inc.July 2025 Weekly Recap & Low Risk High Reward Trade Ideas - Newser
Ardelyx (ARDX) Appoints New Chief Business and HR Officers - MSN
Ardelyx Inc. Breaks Below Key Support LevelMarket Activity Report & Daily Technical Forecast Reports - 선데이타임즈
Pattern Scan Adds Ardelyx Inc. to WatchlistJuly 2025 Catalysts & High Accuracy Buy Signal Tips - sundaytimes.kr
Ardelyx's Accelerating Revenue Growth and Strategic Momentum in 2025: A Deep Dive into IBSRELA's Surge and XPHOZAH's Resilience - AInvest
Ardelyx: Improved Outlook For Ibsrela And Xphozah (NASDAQ:ARDX) - Seeking Alpha
Ardelyx (ARDX) Is Up 10.6% After Raising 2025 IBSRELA Sales Guidance and Posting Strong Q2 Results - simplywall.st
Blair William & Co. IL Boosts Stake in Ardelyx, Inc. (NASDAQ:ARDX) - Defense World
Ardelyx Inc. Flashes Rebound Signal in Oversold Condition2025 Earnings Surprises & Community Consensus Stock Picks - beatles.ru
Ardelyx Inc Stock (ARDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
8.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):